Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Crossover, Pilot Stage Clinical Trial Evaluating CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
NCT06007235 is registered in ClinicalTrials.gov with Organ, Tissue, Regeneration, Repair and Replacement as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Crossover, Pilot Stage Clinical Trial Evaluating CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
- Lead sponsor
- Organ, Tissue, Regeneration, Repair and Replacement
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 29, 2024
- Completion date
- September 30, 2024
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.